Log In
Print
BCIQ
Print
Print this Print this
 

IW-9179

  Manage Alerts
Collapse Summary General Information
Company Ironwood Pharmaceuticals Inc.
DescriptionGuanylate cyclase C (GCC; GUCY2C) agonist
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionGuanylate cyclase C agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDyspepsia
Indication DetailsTreat functional dyspepsia (FD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today